Choosing pharmacotherapy for bipolar disorder requires a risk-benefit analysisNovember 4, 2020Bipolar DisorderADHDAnxiety Disorders
Survey finds European dermatologists unhappy with pandemic teledermatology experienceNovember 3, 2020COVID-19 UpdatesBusiness of Medicine
Let side effects guide treatment choice for refractory OCDNovember 3, 2020Obsessive-Compulsive DisorderDepressionMajor Depressive Disorder
Decide ADHD pharmacotherapy based on medication onset, duration of actionOctober 28, 2020ADHDPediatrics
Valvular disease and COVID-19 are a deadly mix; don’t delay interventionOctober 27, 2020COVID-19 Updates
When should students resume sports after a COVID-19 diagnosis?October 23, 2020COVID-19 UpdatesPediatrics
Data on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020COVID-19 Updates
